Refine
Has Fulltext
- no (21)
Year of publication
- 2012 (21) (remove)
Document Type
- Article (18)
- Conference Proceeding (2)
- Review (1)
Language
- English (21)
Is part of the Bibliography
- yes (21)
Keywords
- Diabetic nephropathy (2)
- Linagliptin (2)
- obesity (2)
- 25-OH vitamin D (1)
- ACE inhibitors (1)
- Acute renal failure (1)
- Angiotensin converting enzyme inhibitor (1)
- Biparietal diameter (1)
- Brain development (1)
- Cardiovascular effects (1)
- Cortisol Maternal cortisol (1)
- DDP-4 inhibition (1)
- DPP-4 inhibitor (1)
- Diabetes (1)
- Dipeptidyl peptidase 4 inhibitor (1)
- Endothelin-1 (1)
- Fetal programming (1)
- Furosemide (1)
- GLP-1 (1)
- Head circumference (1)
- Heart failure (1)
- Kidney (1)
- Loop diuretics (1)
- Mortality (1)
- Myocardial infarction (1)
- Renal failure (1)
- Renin-angiotensin system (1)
- Renin-angiotensin-aldosterone system (1)
- Shan He Jian Fei Granules (SHJFG) (1)
- adiponectin (1)
- angiotensin receptor blockers (1)
- blood biomarker (1)
- capillary blood (1)
- clusterin (1)
- diabetic nephropathy (1)
- distal convoluted tubule (1)
- endothelin receptors (1)
- fasting blood glucose (1)
- filter paper (1)
- glycemic control (1)
- heart-type fatty acid binding protein (1)
- high-fat diet (1)
- in situ hybridization (1)
- kidney (1)
- kidney injury molecule 1 (1)
- leptin (1)
- lipid (1)
- mouse (1)
- nephrin (1)
- neutrophil gelatinase-associated lipocalin (1)
- new analysis method (1)
- osteopontin (1)
- pregnancy (1)
- ramipril (1)
- resistin (1)
- telmisartan (1)
- tissue inhibitior of metalloproteinases 1 (1)
- transient receptor potential (1)
- urinary biomarker (1)
- vesicular trafficking (1)
- weight loss (1)
OBJECTIVE-BMI and albumin are commonly accepted parameters to recognize wasting in dialysis patients and are powerful predictors of morbidity and mortality. However, both parameters reveal limitations and may not cover the entire range of patients with wasting. The visceral protein transthyretin (TTR) may be helpful in overcoming the diagnostic and prognostic gap. Therefore, the aim of this study was to assess the association of TTR with morbidity and mortality in hemodialysis patients.
RESEARCH DESIGN AND METHODS-The TTR concentration was determined in plasma samples of 1,177 hemodialysis patients with type 2 diabetes. Cox regression analyses were used to determine hazard ratios (HRs) for the risk of cardiovascular end points (CVEs) and mortality according to quartiles of TTR concentration for the total study cohort and the subgroups BMI >= 23 kg/m(2), albumin concentration >= 3.8 g/dL, and a combination of both.
RESULTS-A low TTR concentration was associated with an increased risk for CVE for the total study cohort (HR 1.65 [95% CI 1.27-2.14]), patients with BMI >= 23 kg/m(2) (1.70 [1.22-2.37]), albumin >= 3.8 g/dL (1.68 [1.17-2.42]), and the combination of both (1.69 [1.13-2.53]). Additionally, a low TTR concentration predicted mortality for the total study cohort (1.79 [1.43-2.24]) and patients with BMI >= 23 kg/m(2) (1.46 [1.09-1.95]).
CONCLUSIONS-The current study demonstrated that TTR is a useful predictor for cardiovascular outcome and mortality in diabetic hemodialysis patients. TTR was particularly useful in patients who were not identified to be at risk by BMI or albumin status.